CLDN6-Targeted ADC QLS5132 Shows Promising Activity in Platinum-Resistant Ovarian Cancer - OncLive
CLDN6-Targeted ADC QLS5132 Shows Promising Activity in Platinum-Resistant Ovarian Cancer OncLive
CLDN6-Targeted ADC QLS5132 Shows Promising Activity in Platinum-Resistant Ovarian Cancer OncLive
Dr Thaker Highlights Survival Benefit With IMNN-001 in Ovarian Cancer Targeted Oncology
6 Symptoms of Uterine, Ovarian, and Cervical Cancer You Shouldn’t Ignore NewYork-Presbyterian
Theolytics announces first patient dosed in the Octopod‑IP trial PharmaTimes
Southeast Minnesotans race for ovarian cancer research KTTC
"My doctor told me I had IBS - it turned out to be ovarian cancer at 22" Yahoo
Rethinking ovarian cancer III: the past decade and future directions Nature
Staten Island health fair brings ovarian cancer awareness, genetic testing May 3 SILive.com
How The NOCC Delivers Free Meals to Patients with Ovarian Cancer Cure Today
Gynecologic Oncologist Dr. Tom Lallas Brings Unique Perspective And De Endometriosis Foundation of America
Inoviq Advances Ovarian Cancer Test and CAR-Exosome Pipeline as Cash Reserves Support Growth TipRanks
Stewart Family, Nighthawk Lacrosse Program Raise Awareness For Ovarian Cancer Support The Newtown Bee
Theolytics Announces First Patient Dosed in the OCTOPOD-IP Trial, a US Phase 1 Trial with THEO-260, a Novel Oncolytic Immunotherapy Targeting Ovarian Cancer The Manila Times
Muaiad Kittaneh Shares Reflections on Ovarian Cancer Strategy – Syneos Health Oncodaily
What Was 2025’s Biggest News in Ovarian Cancer? Oncology News Central
New drug may extend survival in aggressive ovarian cancer, trial shows The Guardian
Correction: The splicing factor WBP11 mediates MCM7 intron retention to promote the malignant progression of ovarian cancer Nature
Theolytics Advances THEO-260 Into Second Clinical Trial for Platinum-Resistant Ovarian Cancer TipRanks
Does AbbVie’s Durham AI Plant and Ovarian Cancer Data Reframe the Bull Case for ABBV? Yahoo Finance
Cleo Diagnostics Starts Staged Manufacturing of Ovarian Cancer Test Kits with Bio-Techne TipRanks
'My doctor told me I had IBS but it was ovarian cancer - I was only 22' Surrey Live
Cannabis derivatives could provide new ovarian cancer treatments Frontiers
I was hungry and looked pregnant - morning sign lead to cancer diagnosis at 22 The Sun
Lung cancer drug offers a surprising new treatment against ovarian cancer Mayo Clinic News Network
Epitopea receives MHRA approval for first-in-human trial of RNA vaccine for ovarian cancer Manufacturing Chemist
Rewiring Immune System Offers New Path to Better Ovarian Cancer Treatment UC San Diego Today
AI-boosted electronic nose detects ovarian cancer Technology Org
INOVIQ advances ovarian cancer test toward US commercialisation Sharecafe
“We Need More Advocacy”: Tackling the Biggest Challenges in Ovarian Cancer Care Oncology News Central
Genomic alterations linked to recurrence risk in high-grade serous ovarian cancer revealed by deep targeted sequencing Nature
More Than a Notch: New Discovery May Improve Ovarian Cancer Treatment UNM HSC Newsroom
'How I knew I had ovarian cancer’: Survivors and caregiver discuss symptoms UT MD Anderson
One Surgery Could Prevent Most Ovarian Cancers The American College of Surgeons
ATOMIC Trial: Immunotherapy for Colon Cancer Cure Today
Arginine dependency in omental metastasis of epithelial ovarian cancer reveals a therapeutic vulnerability Nature
Using CAR-T cells to treat ovarian cancer Stanford Medicine
Immunocompetent C57BL/6 syngeneic mouse ovarian cancer models with defined genetic alterations Nature
Shining a Light on New Approaches for Ovarian Cancer Treatment and Detection American Association for Cancer Research (AACR)
UCLA scientists develop off-the-shelf immunotherapy for ovarian cancer Newsroom | UCLA
Transglutaminase 2 exacerbates ovarian cancer survival by directly inactivating GSK3β Nature